Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis

Wen Xu(City University of Hong Kong, Shenzhen Research Institute), Bin Li(First Affiliated Hospital of Henan University)

EBioMedicine

May 4, 2023

10.1016/j.ebiom.2023.104587

Cited by 25

Related Papers

Targeting PI3K/Akt signal transduction for cancer therapy

|Signal Transduction and Targeted Therapy|2021|1.7k

Advances in targeted therapy for esophageal cancer

|Signal Transduction and Targeted Therapy|2020|546

Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment

|MedComm|2021|369

Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy

|Oncotarget|2017|114

Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3

|Cancer Research|2022|86